This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

20171027 PLA call

From HL7Wiki
Jump to navigation Jump to search

return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program

HL7 PLA Call Minutes


Date: 2017-10-27
Time: 11:30 AM
Facilitator Mary Kay/ Austin Note taker(s) Anne
Attendee Name

x Calvin Beebe
x Lorraine Constable
Jean Duteau,
Tony Julian
Paul Knapp
x Austin Kreisler,
x Mary Kay McDaniel
Brian Pech
Wayne Kubick
x John Roberts
Andy Stechishin
no quorum definition


Agenda review

  • Notes of 20171013_PLA_call review
  • Status updates for CDAMG and CIMI MG
  • notional division of products into product families and lines, to provide examples for peer review.
    • Level of granularity
    • Identify which pieces are orphaned, and the political elements to be surfaced.
    • Positioning cross-product family artifacts (standards naming)
  • BAM-lite feedback and review
    • Governance on V2.x (v2.9 substantive changes)
    • develop form to request establishing a Product Family


Agenda review

  • Notes of 20171013_PLA_call review
  • Mary Kay got list of products and published artifacts for CDA from Dave/Lynn. Sent out to group.
    • ACTION: Anne add TSC agenda item for TSC endorsing Structured Documents being lead methodology group for CDA product family.
      • Austin notes that working on templates for C-CDA will have to start being farmed out to other groups.
    • Lorraine: They have been working through getting things under one umbrella; met with Publishing WG to work on web-based publishing.
    • They have been talking about detailed clinical models. They are anxious to get them out and usable, but the reference model changes are coming in and will create large changes preventing going to ballot. Want to get them out, published, and reviewed in a less formal form than the full ballot, then into the ballot on a different cycle - so a non-ballot review process. As we get CIMI-MG stood up, it's another thing to sort out.
    • ACTION: Add discussion topic for SGB: Product families develop an approach to indicating the maturity of the products
  • For next time: Candidate selection for CIMI and V2 mgmgt group

Meeting Outcomes

Next Meeting/Preliminary Agenda Items

© 2017 Health Level Seven® International. All rights reserved